Bruker Daltonics Announces Selection for Phase II of the ARFCAM R&D Project by the Department of Homeland Security
Bruker Daltonics NBC Detection Corporation has announced that it has received a $0.75 million follow-on Phase II contract award for further research and development into the Autonomous Rapid Facility Chemical Agent Monitor (ARFCAM) from the U.S. Department of Homeland Security. ARFCAM is intended to be the next generation chemical agent monitor for government facilities.
Frank Thibodeau, Vice President for NBC Business Development, commented: “This award indicates that Bruker Daltonics has performed well in Phase I and has unique expertise to design and deliver the next-generation technology to help protect our country from the threat of chemical terrorism. This is a challenging program with accelerated timelines and ambitious technical specifications, and we are gratified that the Department of Homeland Security has shown confidence in the ability of Bruker Daltonics to meet these requirements.”
ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)
Bruker BioSciences, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry, as well as a developer and provider of nuclear, biological and chemical (NBC) detection systems. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. For more information about Bruker BioSciences Corporation, please visit www.bruker-biosciences.com
